Molina Healthcare (NYSE:MOH) Raised to Hold at Zacks Research

Molina Healthcare (NYSE:MOH) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

MOH has been the subject of a number of other reports. Wells Fargo & Company set a $141.00 price target on shares of Molina Healthcare and gave the company an “equal weight” rating in a research report on Friday, February 20th. The Goldman Sachs Group reduced their price target on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research report on Wednesday, February 11th. Deutsche Bank Aktiengesellschaft set a $310.00 target price on shares of Molina Healthcare in a research report on Friday, March 13th. Wall Street Zen upgraded shares of Molina Healthcare from a “strong sell” rating to a “sell” rating in a research report on Sunday. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and an average price target of $169.21.

Molina Healthcare Price Performance

Shares of MOH traded up $1.63 during mid-day trading on Monday, reaching $152.63. 551,315 shares of the stock traded hands, compared to its average volume of 1,734,731. The firm has a fifty day moving average price of $143.54 and a 200 day moving average price of $159.39. The company has a market cap of $7.95 billion, a price-to-earnings ratio of 17.83 and a beta of 0.55. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 1 year low of $121.06 and a 1 year high of $333.22.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The firm had revenue of $11.38 billion for the quarter, compared to analysts’ expectations of $10.90 billion. Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter last year, the firm earned $5.05 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities research analysts predict that Molina Healthcare will post 5.03 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its position in Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its position in Molina Healthcare by 10.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock worth $376,831,000 after acquiring an additional 201,772 shares in the last quarter. Invesco Ltd. grew its position in Molina Healthcare by 24.2% in the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after acquiring an additional 329,679 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Molina Healthcare by 46.4% in the fourth quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after purchasing an additional 447,078 shares during the last quarter. Finally, 8 Knots Management LLC bought a new stake in Molina Healthcare in the fourth quarter worth $198,942,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.